Sumitomo Dainippon Pharma Co., Ltd.
Records under this name other than the patents Sumitomo Dainippon Pharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Sumitomo Dainippon Pharma Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,273,148 | Method for Cancer Immunotherapy Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,765,114 | Method for cancer immunotherapy Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,575,308 | Method for cancer immunotherapy Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,980,316 | Stable Tablet Containing Droxidopa Formerly held In force · High confidence | In force | High confidence | |
| US 7,939,627 | Peptides Comprising an Epitope of the Wilms Tumor Gene Product Formerly held In force · High confidence | In force | High confidence | |
| US 8,067,413 | 9-Substituted-8-OXO-ADENINE Compounds as Toll-Like Receptor (TLR7 ) Modulators Formerly held In force · High confidence | In force | High confidence | |
| US 7,906,510 | Amide Derivative and Pharmaceutical Composition Containing the Same Formerly held In force · High confidence | In force | High confidence | |
| US 8,178,102 | Emulsified Composition for Dilution and Cancer Vaccine Composition Formerly held In force · High confidence | In force | High confidence | |
| US 8,541,544 | Molecular marker for cancer stem cell Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,399,760 | Molecular marker for cancer stem cell Formerly held In force · USPTO record | In force | USPTO record |